BioMed Realty Trust Reports Second Quarter 2008 Financi...(ate of 3.7% atquarter-end; and $484.0 mi...),Health

Date:7/30/2008

ate of 3.7% at quarter-end; and $484.0 million in outstanding borrowings under the company's acquisition and construction loan secured by the Center for Life Science | Boston property, with a weighted-average effective interest rate of 3.7% at quarter-end. The company's debt to total capitalization ratio was 42.0% at June 30, 2008.

"We continue to maintain an appropriately conservative capital structure, and further enhanced our strong liquidity position with our April 2008 common stock offering. Owing to our consistently prudent approach to addressing our capital needs, we are uniquely well-positioned, with capacity to fully fund the completion of our current development projects and to selectively pursue additional attractive investment opportunities," commented Kent Griffin, Chief Financial Officer of BioMed Realty Trust.

Portfolio Update

During the quarter, the company acquired the minority interest in the entity that owns the Waples property for approximately $1.8 million; as a result, the company owns 100% of the property.

As of June 30, 2008, BioMed Realty Trust owned or had interests in 112 buildings, located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. The company's portfolio was comprised of the following, with its operating portfolio 93.2% leased to 114 tenants, as of June 30, 2008:

Rentable

Square Feet

Operating portfolio 6,672,086

Repositioning and redevelopment properties 1,816,642

Construction in progress 1,941,000

Total portfolio 10,429,728

Land parcels 1,367,000

Total proforma portfolio 11,796,728

Quarterly Distr
'/>"/>

SOURCE BioMed Realty Trust, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends